Senior insider sale
KYVERNA THERAPEUTICS, INC. — senior position signals high conviction
$303.0K
34.21K shares
What this filing means
SPIEGELMAN DANIEL K plans to sell 34.21K shares of KYVERNA THERAPEUTICS, INC. valued at approximately $303.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/7/2026ACC: 0001950047-26-003285
Director
Since Feb 2024
34.21K
Shares to sell
$303.0K
Approx. market value
17.58K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Stock Option Exercise
Cash
4/7/2026
17.58KTotal acquired17.58K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
4/7/2026 | Stock Option Exercise Cash | 17.58K | — |
| Total | 17.58K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
16.63K
Market value
$140.4K
3/31/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
17.58K
Market value
$162.6K
4/7/2026
Total
Units
34.21K
Value
$303.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/31/2026 | 16.63K | $140.4K | — | Completed |
| Planned — Approximate Date | ||||
4/7/2026 | 17.58K | $162.6K | NASDAQ | Planned |
| Total | 34.21K | $303.0K | ||